MRN3 3x Long Mrna

Leverage Shares plc

26 February 2025

THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF THE HOLDERS OF THE ETP SECURITIES. IF ANY ETP SECURITYHOLDER IS IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD CONSULT THEIR OWN INDEPENDENT PROFESSIONAL ADVISERS IMMEDIATELY

If you have recently sold or otherwise transferred your entire holding(s) of ETP Securities referred to below, you should immediately forward this document to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee.

Notice to ETP Securityholders of the following Series of ETP Securities issued by Leverage Shares plc (the "Issuer"):

Leverage Shares 3x Long Moderna (MRNA) ETP Securities

(ISIN: XS2675718725)

(the "Relevant Series")

Capitalised terms used, but not defined, in this notice shall have the meaning given thereto in the Notice of Adjourned Meeting of ETP Securityholders of the Relevant Series dated 11 February 2025 and the Amended and Restated Master Definitions Schedule in relation to the Leverage Shares plc collateralised exchange traded securities programme dated 17 July 2024.

On 26 February 2025 the Issuer announced that the ETP Securityholders of the Relevant Series approved the Consolidation of the ETP Securities of the Relevant Series.

The Consolidation will apply to ETP Securityholders of record as of the close of markets on 3 March 2025. The first trading date of the Consolidated ETP Securities will be 4 March 2025. If, as a result of the Consolidation an ETP Securityholder would become entitled to a fraction of an ETP Security, the Issuer will redeem such fractional ETP Security on 3 March 2025.

The Consolidation will be effected by a Consolidation Supplemental Trust Deed.

Details of the Consolidation are set out in the table below: